Edition:
India

Five Prime Therapeutics Inc (FPRX.OQ)

FPRX.OQ on NASDAQ Stock Exchange Global Select Market

11.91USD
18 Apr 2019
Change (% chg)

-- (--)
Prev Close
$11.91
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
114,917
52-wk High
$19.70
52-wk Low
$7.84

About

Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company focused on discovering and developing protein therapeutics. The Company's product candidates include Cabiralizumab (FPA008), which is an antibody that inhibits colony stimulating factor-1 receptor, that it is studying in clinical trials as a monotherapy in... (more)

Overall

Beta: 4.21
Market Cap(Mil.): $1,122.56
Shares Outstanding(Mil.): 28.90
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates